These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 6801857)

  • 21. [Prevention of Rh-sensitization with the use of anti-D gamma-globulin after delivery].
    Keserü TL; Kaiser G; Annus J
    Zentralbl Gynakol; 1971 Jan; 93(1):24-9. PubMed ID: 4102084
    [No Abstract]   [Full Text] [Related]  

  • 22. Distribution of IgG subtypes in maternal anti-D sera and their prognostic value in Rh haemolytic disease of the new-born.
    Iyer YS; Kulkarni SV; Gupte SC
    Acta Haematol; 1992; 88(2-3):78-81. PubMed ID: 1466203
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The prevention of rhesus immunization with anti-rhesus (D) immunoglobulin. Report of a clinical study carried out in Dutch hospitals].
    Dudok De Wit C; Borst-Eilers E; van der Weerdt CM; Kloosterman GJ
    Ned Tijdschr Geneeskd; 1968 Dec; 112(52):2345-51. PubMed ID: 4974070
    [No Abstract]   [Full Text] [Related]  

  • 24. Immunization of animals with anti-D immunoglobulin used for prophylaxis of hemolytic disease of newborns. 3. Antiglobulin immune antibodies obtained by immunizing rabbits with IgG anti-D immunoglobulin and their pattern in immunodiffusion and immunoelectrophoresis.
    Polak S; Marzec Z; Skorczyński M; Styblińska M
    Arch Immunol Ther Exp (Warsz); 1972; 20(5):687-92. PubMed ID: 4632604
    [No Abstract]   [Full Text] [Related]  

  • 25. [Treatment of a positive Rhesus D neonate born of a mother with idiopathic thrombopenic purpura with anti-D immunoglobulins (Rh O)].
    di Maria H; Parnet Mathieu F; Rio di Maria D; Maigret P; Gire R; Guillot F; Lasfargues G; Brossard Y
    Arch Fr Pediatr; 1990 Feb; 47(2):125-7. PubMed ID: 2158285
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Conditions of the prevention of neonatal hemolytic diseases resulting from Rh(D) incompatibility in Hungary].
    Simonovits I; Garancsy L; Böröcz I
    Orv Hetil; 1980 Apr; 121(15):875-8. PubMed ID: 6770319
    [No Abstract]   [Full Text] [Related]  

  • 27. [2-stage determination of rhesus classification].
    Zhiburt EB; Andreeva LS; Savel'eva LP; Serebrianaia NB; Sidorkevich SV
    Klin Lab Diagn; 1996; (3):29-30. PubMed ID: 8925209
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Prevention of Rh-immunization with the Rho(D)-immunoglobulin G (RhoGAM)].
    Robertson JG
    Med Welt; 1970 Nov; 46():1991-5. PubMed ID: 4997857
    [No Abstract]   [Full Text] [Related]  

  • 29. The prevention of rhesus immunization.
    Robertson EG; Farrell AG; Du Toit I; Kent A
    S Afr Med J; 1971 Nov; 45(44):1247-9. PubMed ID: 5002433
    [No Abstract]   [Full Text] [Related]  

  • 30. Early plasmapheresis followed by high-dose γ-globulin treatment saved a severely Rho-incompatible pregnancy.
    Isojima S; Hisano M; Suzuki T; Sago H; Murashima A; Yamaguchi K
    J Clin Apher; 2011; 26(4):216-8. PubMed ID: 21506141
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Flow cytometric analyses of the subclasses of red cell IgG antibodies.
    Lynen R; Neuhaus R; Schwarz DW; Simson G; Riggert J; Mayr WR; Köhler M
    Vox Sang; 1995; 69(2):126-30. PubMed ID: 8585193
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Anti-D-IgG-prevention (Rhesus-prevention)].
    Wien Med Wochenschr; 1969 Jul; 119(30):558-9. PubMed ID: 4981872
    [No Abstract]   [Full Text] [Related]  

  • 33. [Preliminary experiences with the prevention of Rh sensitization].
    Aeppli H; Nwebube G
    Gynaecologia; 1969; 168(6):481-3. PubMed ID: 4993890
    [No Abstract]   [Full Text] [Related]  

  • 34. Proceedings: Ante-natal plasmapheresis in severe rhesus iso-immunization.
    Fraser ID; Bennett MO; Bothamley JE
    Br J Haematol; 1974 Sep; 28(1):147. PubMed ID: 4213315
    [No Abstract]   [Full Text] [Related]  

  • 35. [Anti-Rh immunoglobulin (D) subclasses and hemolytic disease of the newborn].
    Cregut R; Pinon F; Brossard Y
    Nouv Presse Med; 1973 Jul; 2(29):1947. PubMed ID: 4198948
    [No Abstract]   [Full Text] [Related]  

  • 36. [Preliminary experiences with ther prevention of Rh sensitization].
    Aeppli H; Nwebube G
    Gynaecologia; 1969; 168(6):481-3. PubMed ID: 4993202
    [No Abstract]   [Full Text] [Related]  

  • 37. Prediction of the severity of haemolytic disease of the newborn. Quantitative IgG anti-D subclass determinations explain the correlation with functional assay results.
    Garner SF; Gorick BD; Lai WY; Brown D; Taverner J; Hughes-Jones NC; Contreras M; Lubenko A
    Vox Sang; 1995; 68(3):169-76. PubMed ID: 7625074
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A review of the production and clinical use of intravenous Anti-D immunoglobulin.
    Walsh TJ; O'Riordan JP
    Ir Med J; 1982 Jul; 75(7):243-4. PubMed ID: 6813287
    [No Abstract]   [Full Text] [Related]  

  • 39. Rhesus haemolytic disease.
    Whitfield CR
    J Clin Pathol Suppl (R Coll Pathol); 1976; 10():54-62. PubMed ID: 823179
    [No Abstract]   [Full Text] [Related]  

  • 40. [Production and use of immunoglobulin G-anti-D].
    Haussmann HG
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1971; 96(2):236-40. PubMed ID: 4111658
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.